 
 
 
 
 
Whom to test? 
(According to WHO Diabetes protocol 2018) 
In asymptomatic people, it is recommended to repeat 
testing to confirm the diagnosis, preferably with the same 
test, as soon as practicable on a subsequent day 
Management of Raised blood sugar 
Management in presence of Ketones 
  
Precautions with antidiabetic drugs 
 
Metformin is contraindicated in 
• people with chronic kidney disease (estimated glomerular filtration 
rate (eGFR) <45 ml/minute/1.73m2) 
• liver disease 
• cardiac/respiratory insufficiency 
• alcohol abuse 
• history of lactic acidosis 
Glibenclamide is not recommended in 
• people aged 60 years or older 
• In patients for whom hypoglycaemia is a concern (people who are at 
risk of falls, people who have impaired awareness of hypoglycaemia, 
people who live alone) 
• people who drive or operate machinery as part of their job 
  
Macrovascular complications 
 
Patients with diabetes are at a higher risk of 
• Coronary heart disease 
• Cerebrovascular disease 
• Peripheral vascular diseases 
Management of CVD risk factors 
in diabetes (hypertension) 
Blood pressure control 
• Blood pressure lowering in people with diabetes reduces 
the risk of microvascular and macrovascular complications 
• Thiazide diuretics and angiotensin-converting enzyme 
(ACE) inhibitors are recommended 
• Target should be to achieve a target blood pressure < 
130/80 mmHg. 
• If this is not achievable, refer to a higher level of care. 
